levodopa's Usage Examples:

reduced risk for motor complications in Parkinson patients relative to levodopa.

experimental drug being studied for the treatment of levodopa-induced dyskinesia.

brand name Ongentys, is a medication which is administered together with levodopa in people with Parkinson"s disease.

counteracting the dyskinesias associated with long term treatment with levodopa and related drugs.

used in the management of Parkinson"s disease in combination with L-DOPA (levodopa) as co-beneldopa (BAN), under the brand names Madopar in the UK and Prolopa.

entacapone stops catechol-O-methyltransferase from breaking down and metabolizing levodopa, resulting in an overall increase of levodopa remaining in the.

methyl ester of levodopa.

This property is significant in that it allows a greater proportion of peripheral levodopa to cross the blood–brain.

It is the ethyl ester of levodopa.

the brand name Nourianz, is a medication used as an add-on treatment to levodopa/carbidopa in adults with Parkinson"s disease (PD) experiencing "off" episodes.

inhibitor BTS 74 398 fails to evoke established dyskinesia but does not synergise with levodopa in MPTP-treated primates".

When taken together with levodopa (L-DOPA) and carbidopa, entacapone stops catechol-O-methyltransferase.

have shown to improve with levodopa or dopamine agonist therapy, or by repleting dopamine in the motivational circuit with stimulants, antidepressants.